Literature DB >> 11067892

CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism.

L Airas1, J Niemelä, S Jalkanen.   

Abstract

CD73 is a GPI-anchored lymphocyte adhesion molecule possessing an ecto-5'-nucleotidase enzyme activity. In this work, we show that engagement of lymphocyte CD73 increases lymphocyte binding to cultured endothelial cells (EC) in an LFA-1-dependent fashion. Engagement of CD73 by an anti-CD73 mAb 4G4 increases the adhesion of lymphocytes to cultured EC by about 80% compared with that of lymphocytes treated with a negative control Ab, and the increased adhesion can be blocked by an anti-CD18 mAb. The CD73-regulated increase in lymphocyte adhesion is not due to a conformational change leading to high-affinity LFA-1 receptors as assayed using mAb 24 against an activation-induced epitope of the molecule. Instead, CD73 engagement induces clustering of LFA-1 that is inhibitable by calpeptin, indicating involvement of Ca(2+)-dependent activation of a calpain-like enzyme in this process. In conclusion, the results shown here demonstrate that CD73 regulates the avidity of LFA-1 by clustering. This indicates a previously undescribed role for CD73 in controlling the poorly characterized activation step in the multistep cascade of lymphocyte extravasation. Moreover, these results suggest that in physiological conditions the activation step may result in clustering of LFA-1 rather than in an affinity change of the molecule.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067892     DOI: 10.4049/jimmunol.165.10.5411

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.

Authors:  Li Wang; Xuerui Zhou; Tingting Zhou; Dong Ma; Sifeng Chen; Xiuling Zhi; Lianhua Yin; Zhimin Shao; Zhouluo Ou; Ping Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

2.  CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes.

Authors:  Masahide Takedachi; Dongfeng Qu; Yukihiko Ebisuno; Hiroyuki Oohara; Michelle L Joachims; Stephanie T McGee; Emiko Maeda; Rodger P McEver; Toshiyuki Tanaka; Masayuki Miyasaka; Shinya Murakami; Thomas Krahn; Michael R Blackburn; Linda F Thompson
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

3.  The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes.

Authors:  Nicola Lo Buono; Rossella Parrotta; Simona Morone; Paola Bovino; Giulia Nacci; Erika Ortolan; Alberto L Horenstein; Alona Inzhutova; Enza Ferrero; Ada Funaro
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

4.  CD73 expression identifies a subset of IgM+ antigen-experienced cells with memory attributes that is T cell and CD40 signalling dependent.

Authors:  Lucas D'Souza; Sneh Lata Gupta; Vineeta Bal; Satyajit Rath; Anna George
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

Review 5.  Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).

Authors:  Marquet Minor; Karel P Alcedo; Rachel A Battaglia; Natasha T Snider
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

Review 6.  Ectoenzymes in leukocyte migration and their therapeutic potential.

Authors:  Marko Salmi; Sirpa Jalkanen
Journal:  Semin Immunopathol       Date:  2014-03-18       Impact factor: 9.623

7.  Anti-CD73 in cancer immunotherapy: awakening new opportunities.

Authors:  Luca Antonioli; Gennady G Yegutkin; Pál Pacher; Corrado Blandizzi; György Haskó
Journal:  Trends Cancer       Date:  2016-02-01

8.  Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.

Authors:  John Stagg; Upulie Divisekera; Nicole McLaughlin; Janelle Sharkey; Sandra Pommey; Delphine Denoyer; Karen M Dwyer; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

9.  Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury.

Authors:  Melanie L Hart; Martina Henn; David Köhler; Doris Kloor; Michel Mittelbronn; Iris C Gorzolla; Gregory L Stahl; Holger K Eltzschig
Journal:  FASEB J       Date:  2008-03-19       Impact factor: 5.191

10.  Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.

Authors:  Paul A Beavis; Upulie Divisekera; Christophe Paget; Melvyn T Chow; Liza B John; Christel Devaud; Karen Dwyer; John Stagg; Mark J Smyth; Phillip K Darcy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.